Prevalence of hepatitis C virus in dialysis patients in Spain. Spanish Multicentre Study Group.
Several studies have reported a high prevalence of hepatitis C virus (HCV) antibodies in dialysis patients. In order to determine HCV prevalence in Spain, we conducted a nationwide survey of patients on several modalities of dialysis. We found a greater HCV antibodies prevalence in dialysis patients than in the healthy Spanish population, and higher prevalence in patients on haemodialysis than in patients on peritoneal dialysis. In addition, the prevalence of HCV antibodies is higher in nurses than in the rest of the dialysis unit staff.
D003625:Data Collection; D005260:Female; D006436:Hemodialysis Units, Hospital; D006437:Hemodialysis, Home / Q000009:adverse effects; D006526:Hepatitis C / Q000453:epidemiology* / Q000209:etiology*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology
D018937:Hepatitis C Antibodies